DEVELOPMENT AND VALIDATION OF A STABILITY-INDICATING RP-HPLC METHOD FOR SIMULTANEOUS DETERMINATION OF BILASTINE, PHENYLEPHRINE, AND DEXTROMETHORPHAN HBR IN FIXED-DOSE COMBINATION.
International Journal of Pharmacological and Pharmaceutical Innovations (IJPPI) · 2026
DOI: 10.67540/ijppi.v1.i2.013 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmacological and Pharmaceutical Innovations (IJPPI), 2026. Verfasst von OMPRAKASH UNIYAL und 1 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
Objective
To design and Performance Evaluation a rapid, stability-indicating, as well as environmentally acceptable reverse-phase chromatographic method for the simultaneous analysis of Bilastine, Phenylephrine Hydrochloride, and Dextromethorphan Hydrobromide in a fixed-dose pharmaceutical formulation.
Methods
Separation of the analytes was carried out on a Luna Omega PS C18-column (100 × 4.6 mm, 3 µm) employing a gradient elution program with mobile phase A consisting of a mixture of buffer and acetonitrile (95:5, v/v) along with mobile phase B with 100% of methanol. A wavelength of 272 nm was selected for analyte monitoring. Chromatographic runs were performed at a flow rate of 1.5 mL/min with a 20 µL injection volume, and all compounds were effectively resolved within 9.0 min. To confirm the suitability of the procedure for routine application, validation was carried out as per ICH recommendations. Parameters validated including specificity, linearity, accuracy, precision, robustness, LOD, LOQ, and stability-indicating characteristics through forced degradation studies.
Results
The method provided complete resolution of all analytes with satisfactory system suitability. Excellent linearity was observed over the tested over the specified analytical ranges, found perfect linearity (R²) of 0.99977 for Bilastine, 0.99978 for Phenylephrine, and 0.99999 for Dextromethorphan Hydrobromide. Method precision showed %RSD values below 2.0%, and recovery values ranged from 98.0% to 102.0% for all analytes. Stress studies verified the stability-indicating nature of the method, with no interference from degradation products. The assay of the marketed formulation was within acceptable limits. The developed method achieved a Blue Applicability Grade Index (BAGI) score of 72/100, indicating moderate green analytical performance.
Conclusion
The proposed RP-HPLC method is simple, precise, accurate, robust, stability-indicating, and environmentally acceptable. The method is suitable for routine quality control and stability studies of Bilastine, Phenylephrine Hydrochloride, and Dextromethorphan Hydrobromide in combined pharmaceutical dosage forms.
Zitieren
APA
UNIYAL, O., & KUMAR, M. (2026). DEVELOPMENT AND VALIDATION OF A STABILITY-INDICATING RP-HPLC METHOD FOR SIMULTANEOUS DETERMINATION OF BILASTINE, PHENYLEPHRINE, AND DEXTROMETHORPHAN HBR IN FIXED-DOSE COMBINATION. International Journal of Pharmacological and Pharmaceutical Innovations (IJPPI). https://doi.org/10.67540/ijppi.v1.i2.013
Vancouver
UNIYAL O, KUMAR M. DEVELOPMENT AND VALIDATION OF A STABILITY-INDICATING RP-HPLC METHOD FOR SIMULTANEOUS DETERMINATION OF BILASTINE, PHENYLEPHRINE, AND DEXTROMETHORPHAN HBR IN FIXED-DOSE COMBINATION. International Journal of Pharmacological and Pharmaceutical Innovations (IJPPI). 2026. doi:10.67540/ijppi.v1.i2.013
BibTeX
@article{UNIYAL2026,
author = {UNIYAL, OMPRAKASH and KUMAR, MANOJ},
title = {DEVELOPMENT AND VALIDATION OF A STABILITY-INDICATING RP-HPLC METHOD FOR SIMULTANEOUS DETERMINATION OF BILASTINE, PHENYLEPHRINE, AND DEXTROMETHORPHAN HBR IN FIXED-DOSE COMBINATION},
journal = {International Journal of Pharmacological and Pharmaceutical Innovations (IJPPI)},
year = {2026},
doi = {10.67540/ijppi.v1.i2.013}
}
EUVIMED